Search results for "EJECTION FRACTION"

showing 10 items of 378 documents

P1699Non-ST segment elevation miocardial infarction (NSTEMI) vs. Unstable angina (UA) in young women aged < 45 years - differences in symptomatolo…

2019

Abstract Background Almost 50% of all ACS in young women are NSTEMI and UA. Due to the type of ACS we observed differences in the symptomatology, treatment and outcomes. The aim was to evaluate the differences in the clinical course and prognosis in young women aged ≤45 years with NSTEMI vs. UA. Methods We compared 1143 women aged ≤45y.o. with acute cardiac syndromes: 51% NSTEMI, 49% UA from the PL-ACS registry between 2007 - 2014. Results Chest pain was predominant in both group, with a higher incidence in NSTEMI group (91.7% vs. 84.7, p=0.0002). UA group was older (42y.o. vs. 41y.o p=0.003), more often presents atypical symptoms (8.0% vs. 1.5%, p<0,0001) mostly with dyspnea (3.9%vs. 1.…

medicine.medical_specialtyEjection fractionUnstable anginabusiness.industryInfarctionClopidogrelmedicine.diseaseChest painRestenosisInternal medicineCardiologymedicineST segmentmedicine.symptomCardiology and Cardiovascular MedicinebusinessKillip classmedicine.drugEuropean Heart Journal
researchProduct

Heart failure with preserved ejection fraction infrequently evolves toward a reduced phenotype in long-term survivors: a long-term prospective longit…

2019

Background: Long-term trajectories of left ventricular ejection fraction (LVEF) in heart failure (HF) patients with preserved EF (HFpEF) remain unclear. Our objective was to assess long-term longitudinal trajectories in consecutive HFpEF patients and the prognostic impact of LVEF dynamic changes over time. Methods and Results: Consecutive ambulatory HFpEF patients admitted to a multidisciplinary HF Unit were prospectively evaluated by 2-dimensional echocardiography at baseline and at 1, 3, 5, 7, 9, and 11 years of follow-up. Exclusion criteria were patients having a previous known LVEF <50%, patients undergoing only 1 echocardiogram study, and those with a diagnosis of dilated, noncompa…

medicine.medical_specialtyEjection fractionVentricular functionbusiness.industryFollow up studiesHeart failureInsuficiència cardíacamedicine.disease:Informàtica [Àrees temàtiques de la UPC]Heart failureInternal medicineCardiologymedicinecardiovascular systemcardiovascular diseasesCardiology and Cardiovascular MedicineHeart failure with preserved ejection fractionbusinesscirculatory and respiratory physiology
researchProduct

Reliability and Accuracy of Echocardiography for Follow-up Studies after Intervention

1987

By two-dimensional echocardiography limitations of M-mode echocardiography have been eliminated. As a direct and noninvasive method two-dimensional echocardiography seems to be an ideal method for analysis of left ventricular function in follow-up studies. In relation to other methods there are no limitations concerning x-ray exposure, physicians and patients safety. Before different studies can be discussed, reliability and accuracy of two-dimensional echocardiography have to be evaluated. Beat-to-beat, day-to-day, intra- and interobserver variability will be discussed, followed by description of follow-up studies after intervention.

medicine.medical_specialtyEjection fractionVentricular functionbusiness.industryIntervention (counseling)Follow up studiesmedicineRadiologyStroke volumebusinessReliability (statistics)
researchProduct

Symmetric dimethylarginine serum level as a new marker of left ventricular ejection fraction in patients with acute myocardial infarction

2013

Purpose: Asymmetric dimethylarginine (ADMA) is a by-product of protein methylation that has been implicated in the prognosis after acute myocardial infarction (MI) and heart failure through Nitric Oxide Synthase (NOS) inhibition. We aimed to investigate whether SDMA – the endogenous symmetrical stereoisomer of ADMA- that has insignificant inhibitory effects on NOS- might be a marker of left ventricular function in acute MI. Methods: Blood samples from 635 consecutive patients hospitalized 1 (23%). Mean LVEF was 55±13%. Mean ADMA, SDMA and L-arg levels were at 0.72±0.42, 0.51±0.44 and 91±54 μmol/L, respectively. Spearman analysis showed that LVEF was correlated negatively with SDMA (r=-0.151…

medicine.medical_specialtyEjection fractionbiologyHomocysteinebusiness.industryRenal functionmedicine.diseaseTroponinchemistry.chemical_compoundBlood pressurechemistryHeart failureInternal medicinemedicinebiology.proteinCardiologycardiovascular diseasesMyocardial infarctionCardiology and Cardiovascular MedicineAsymmetric dimethylargininebusinessEuropean Heart Journal
researchProduct

Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina

2002

Background — Interleukin (IL)-18 plays a central role in orchestrating the cytokine cascade and accelerates atherosclerosis and plaque vulnerability in animal models. However, epidemiological data evaluating the role of IL-18 levels in atherosclerosis are lacking. Methods and Results — In a prospective study of 1229 patients with documented coronary artery disease, we measured baseline serum concentrations of IL-18 and other markers of inflammation. During the follow-up period (median, 3.9 years), 95 patients died of cardiovascular causes. Median serum concentrations of IL-18 were significantly higher among patients who had a fatal cardiovascular event than among those who did not (68.4 ve…

medicine.medical_specialtyEjection fractionbiologyUnstable anginabusiness.industryC-reactive proteinInterleukinmedicine.diseaseCoronary artery diseaseAnginaEndocrinologyPhysiology (medical)Internal medicinemedicinebiology.proteinCardiologyRisk factorCardiology and Cardiovascular MedicineInterleukin 6businessCirculation
researchProduct

0137 : Takotsubo cardiomyopathy following acute cerebral events

2016

International audience; ObjectiveTakotsubo cardiomyopathy is characterized by a transient apical ventricular dysfunction typically induced by an acute stress. Acute cerebral events including ischemic stroke (IS) or Epileptic Event (EE) may both be associated with massive catecholamine release. We aimed to identify the characteristics and outcomes of patients who experienced Takotsubo syndrome complicating an IS or EE.MethodsBetween 2008 and 2013, 87 patients were admitted in our Intensive Care Unit for suspected Takotsubo syndrome, of whom 6 previously experienced acute cerebral symptoms with either IS or EE, within two days. Takotsubo syndrome was diagnosed on Cardiac Magnetic Resonance, e…

medicine.medical_specialtyEjection fractionbiologybusiness.industryCardiomyopathy[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.diseaseTransient apical ventricular dysfunctionCulpritTroponinHemiparesis[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Heart failureT waveInternal medicinemedicinebiology.proteinCardiologyST segmentTakotsubo cardiomyopathymedicine.symptombusinessCardiology and Cardiovascular MedicineComputingMilieux_MISCELLANEOUSArchives of Cardiovascular Diseases Supplements
researchProduct

Effects of Two Different ACE Inhibitors, Captopril and Delapril, in the Early Phases of Acute Anterior Myocardial Infarction

1999

Objective: This study was aimed at investigating the effects of captopril or delapril before and just after thrombolysis in acute anterior myocardial infarction (AMI). Patients and Methods: Study participants consisted of 89 patients, hospitalised within 4 hours of the onset of symptoms. Patients were randomly divided into two groups: the first group (45 patients, pretreatment group) received captopril 6.25mg or delapril 7.5mg orally about 15 minutes before intravenous administration of recombinant tissue plasminogen activator (rt-PA) 100mg; the second group (44 patients, late-treatment group) received captopril or delapril about 4 to 6 hours after thrombolytic treatment. Captopril/delapril…

medicine.medical_specialtyEjection fractionbiologybusiness.industrymedicine.medical_treatmentDelaprilCaptoprilGeneral MedicineThrombolysismedicine.diseaseBlood pressureHeart failureInternal medicinemedicinebiology.proteinCardiologyPharmacology (medical)Creatine kinasecardiovascular diseasesMyocardial infarctionbusinessmedicine.drugClinical Drug Investigation
researchProduct

Role of antiangiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction

2021

Abstract Introduction and objectives Angiogenesis helps to reestablish microcirculation after myocardial infarction (MI). In this study, we aimed to further understand the role of the antiangiogenic isoform vascular endothelial growth factor (VEGF)-A165b after MI and to explore its potential as a coadjuvant therapy to coronary reperfusion. Methods Two mice MI models were formed: a) permanent coronary ligation (nonreperfused MI); b) transient 45-minute coronary occlusion followed by reperfusion (reperfused MI); in both models, animals underwent echocardiography before euthanasia at day 21 after MI induction. We determined serum and myocardial VEGF-A165b levels. In both experimental MI models…

medicine.medical_specialtyEjection fractionbusiness.industryAngiogenesisGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseMicrocirculationBlockadeVascular endothelial growth factor03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistryCoronary occlusionHeart failureInternal medicinemedicineCardiologyMyocardial infarctionbusinessRevista Española de Cardiología (English Edition)
researchProduct

0058 : Low circulating levels of Growth Differentiation Factor 15 (GDF-15) before coronary artery bypass surgery may predict post-operative atrial fi…

2015

BackgroundPost-operative atrial fibrillation (POAF) following cardiac surgery has a high prevalence and is associated with considerable morbidity.AimsTo assess the role of GDF-15, a member of the TGFβsuperfamily, as a potential new predictor of POAF after off-pump (OFP) and on-pump (ONP) coronary artery bypass graft (CABG) surgery.MethodsThis observational study recruited the first 50 patients planned for OFP surgery and the first 50 patients planned for ONP surgery. Patients referred for CABG with the following exclusion criteria: age 80 years, previous atrial fibrillation/flutter, previous treatment with Amiodarone, previous cardiac surgery, emergency surgery. Included patients were equip…

medicine.medical_specialtyEjection fractionbusiness.industryAtrial fibrillationEuroSCOREAmiodaronemedicine.diseaseCardiac surgeryCoronary artery bypass surgerymedicine.anatomical_structureInternal medicineCardiologymedicinecardiovascular diseasesGDF15businessCardiology and Cardiovascular Medicinemedicine.drugArteryArchives of Cardiovascular Diseases Supplements
researchProduct

Association between silent atrial fibrillation and heart failure after acute myocardial infarction

2013

medicine.medical_specialtyEjection fractionbusiness.industryCardiogenic shock12 lead ecgAtrial fibrillationmedicine.diseaseHeart failureInternal medicineHospital admissionmedicineCardiologyMyocardial infarctionCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct